Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-Analysis

EBioMedicine

Volumn 11, Issue , 2016, Pages 219-226

  Chen, Li Shiun ^a,b   Baker, Timothy ^c   Hung, Rayjean J ^d   Horton, Amy ^a   Culverhouse, Robert ^a   Hartz, Sarah ^a   Saccone, Nancy ^a   Cheng, Iona ^e   Deng, Bo ^f   Han, Younghun ^g   Hansen, Helen M ^h   Horsman, Janet ⁱ   Kim, Claire ^j   Rosenberger, Albert ^k   Aben, Katja K ^l   Andrew, Angeline S ^g   Chang, Shen Chih ^j   Saum, Kai Uwe ^m   Dienemann, Hendrik ^n,o   Hatsukami, Dorothy K ^p   Johnson, Eric O ^q   Pande, Mala ^r   Wrensch, Margaret R ^h   McLaughlin, John ^s   Skaug, Vidar ^t   van der Heijden, Erik H ^l   Wampfler, Jason ^f   Wenzlaff, Angela ^u   Woll, Penella ⁱ   Zienolddiny, Shanbeh ^t   Bickeböller, Heike ^k   Brenner, Hermann ^m   Duell, Eric J ^v   Haugen, Aage ^t   Brüske, Irene ^w   Kiemeney, Lambertus A ^l   Lazarus, Philip ^x   Le Marchand, Loic ^y   Liu, Geoffrey ^z   Mayordomo, Jose ^aa   Risch, Angela ^m,o,ab,ac   Schwartz, Ann G ^u   Teare, M Dawn ^ad   Wu, Xifeng ^r   Wiencke, John K ^h   Yang, Ping ^f   Zhang, Zuo Feng ^j   Spitz, Margaret R ^ae   Amos, Christopher I ^g   Bierut, Laura J ^a,b   more..

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

^e CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^f Mayo Clinic College of Medicine   (United States)

^g DARTMOUTH MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^l RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^m GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁿ UNIVERSITY OF HEIDELBERG   (Germany)

^o MEMBER OF THE GERMAN CENTER FOR LUNG RESEARCH DZL   (Germany)

^p UNIVERSITY OF MINNESOTA   (United States)

^q RTI INTERNATIONAL   (United States)

^r UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^s PUBLIC HEALTH ONTARIO   (Canada)

^t NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^u WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^w INSTITUTE OF EPIDEMIOLOGY   (Germany)

^x WASHINGTON STATE UNIVERSITY   (United States)

^y UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^z PRINCESS MARGARET HOSPITAL   (Canada)

^aa UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^ab UNIVERSITY OF SALZBURG   (Austria)

^ac Salzburg Cancer Research Institute   (Austria)

^ad UNIVERSITY OF SHEFFIELD   (United Kingdom)

^ae BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Genetics; Lung cancer; Meta analysis; Smoking cessation

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KNOWLEDGE; LUNG CANCER; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING CESSATION; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; ALLELE; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; LUNG NEOPLASMS; ODDS RATIO; ONSET AGE; PROGNOSIS; RISK;

CHRNA5 PROTEIN, HUMAN; NERVE PROTEIN; NICOTINIC RECEPTOR;

AGE OF ONSET; ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; NERVE TISSUE PROTEINS; ODDS RATIO; PROGNOSIS; RECEPTORS, NICOTINIC; RISK; SMOKING; SMOKING CESSATION;

EID: 84994860533     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.08.012     Document Type: Article

References (44)

1. Altshuler, D.M., Gibbs, R.A., Peltonen, L., et al. Integrating common and rare genetic variation in diverse human populations. Nature 467:7311 (2010), 52–58.
2. American Cancer Society, Cancer Facts and Figures. 2014.
3. Amos, C.I., Wu, X., Broderick, P., et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40:5 (2008), 616–622.
4. Baker, T.B., Weiss, R.B., Bolt, D., et al. Human neuronal acetylcholine receptor A5-A3-B4 haplotypes are associated with multiple nicotine dependence phenotypes. Nicotine Tob. Res. 11:7 (2009), 785–796.
5. Bergen, A.W., Javitz, H.S., Krasnow, R., et al. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet. Genomics 23:2 (2013), 94–103.
6. Bierut, L.J., Madden, P.A., Breslau, N., et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 16:1 (2007), 24–35.
7. Bierut, L.J., Stitzel, J.A., Wang, J.C., et al. Nicotine dependence and the a5-a3-b4 nicotinic receptor gene cluster: variants in the nicotinic receptors Alter the risk for nicotine dependence. Am. J. Psychiatr. 9:165 (2008), 1163–1171.
8. Bierut, L.J., Stitzel, J.A., Wang, J.C., et al. Variants in nicotinic receptors and risk for nicotine dependence. Am. J. Psychiatry 165:9 (2008), 1163–1171.
9. Bloom, A.J., Hartz, S.M., Baker, T.B., et al. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. Ann. Am. Thorac. Soc. 11:7 (2014), 1003–1010.
10. Brennan, P., Hainaut, P., Boffetta, P., Genetics of lung-cancer susceptibility. Lancet Oncol. 12:4 (2011), 399–408.
11. Centers for Disease Control and Prevention, National Center for Health Statistics, CDC Wonder Online Database, Compiled From Compressed Mortality File 1999–2010 Series 20 No. 2P. 2013.
12. Chen, L.S., Baker, T.B., Piper, M.E., et al. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success. Am. J. Psychiatry 169:7 (2012), 735–742.
13. Chen, L.S., Hung, R.J., Baker, T., et al. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis-a meta-analysis. J. Natl. Cancer Inst., 107(5), 2015.
14. Chen, L.S., Baker, T.B., Jorenby, D., et al. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. Drug Alcohol Depend. 154 (2015), 278–282.
15. Durbin, R.M., Abecasis, G.R., Altshuler, D.L., et al. A map of human genome variation from population-scale sequencing. Nature 467:7319 (2010), 1061–1073.
16. Gallagher, K.M., Updegraff, J.A., Health message framing effects on attitudes, intentions, and behavior: a meta-analytic review. Ann. Behav. Med. 43:1 (2012), 101–116.
17. General, S., The Health Consequences of Smoking. 2014.
18. Howlader, N., Noone, A.M., Krapcho, M., et al. Seer Cancer Statistics Review, 1975–2010. http://seer.cancer.gov/csr/1975_2010/, 2013 (accessed April 2013).
19. Hung, R.J., McKay, J.D., Gaborieau, V., et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.[see comment]. Nature 452:7187 (2008), 633–637.
20. Hung, R.J., Christiani, D.C., Risch, A., et al. International lung cancer consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol. Biomark. Prev. 17:11 (2008), 3081–3089.
21. Jha, P., Ramasundarahettige, C., Landsman, V., et al. 21st-century hazards of smoking and benefits of cessation in the United States. N. Engl. J. Med. 368:4 (2013), 341–350.
22. Ji, X., Gui, J., Han, Y., et al. The role of haplotype in 15q25.1 locus in lung cancer risk: results of scanning chromosome 15. Carcinogenesis 36:11 (2015), 1275–1283.
23. Kuryatov, A., Berrettini, W., Lindstrom, J., Acetylcholine receptor (AChR) alpha5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (alpha4beta2)alpha5 AChR function. Mol. Pharmacol. 79:1 (2011), 119–125.
24. Le Marchand, L., Derby, K.S., Murphy, S.E., et al. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine. Cancer Res. 68:22 (2008), 9137–9140.
25. Lips, E.H., Gaborieau, V., McKay, J.D., et al. Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. Int. J. Epidemiol. 39:2 (2010), 563–577.
26. Liu, J.Z., Tozzi, F., Waterworth, D.M., et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 42:5 (2010), 436–440.
27. Lumley, T., rmeta: Meta-analysis. R Package Version 2.15, 2012.
28. Munafo, M.R., Johnstone, E.C., Walther, D., Uhl, G.R., Murphy, M.F., Aveyard, P., CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine Tob. Res. 13:10 (2011), 982–988.
29. Pillai, S.G., Ge, D., Zhu, G., et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet., 5(3), 2009, e1000421.
30. Saccone, N.L., Culverhouse, R.C., Schwantes-An, T.H., et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet. 6:8 (2010), 1–16.
31. Sarginson, J.E., Killen, J.D., Lazzeroni, L.C., et al. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B:3 (2011), 275–284.
32. Sherry, S.T., Ward, M.H., Kholodov, M., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29:1 (2001), 308–311.
33. Spitz, M.R., Amos, C.I., Dong, Q., Lin, J., Wu, X., The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J. Natl. Cancer Inst. 100:21 (2008), 1552–1556.
34. Subcommittee on Biochemical Verification SRNT, Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4:2 (2002), 149–159.
35. TAG, Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 42:5 (2010), 441–447.
36. Thorgeirsson, T.E., Geller, F., Sulem, P., et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:3 (2008), 638–642.
37. Thorgeirsson, T.E., Gudbjartsson, D.F., Surakka, I., et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet. 42:5 (2010), 448–453.
38. Timofeeva, M.N., Hung, R.J., Rafnar, T., et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum. Mol. Genet. 21:22 (2012), 4980–4995.
39. Tseng, T.S., Park, J.Y., Zabaleta, J., et al. Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. PLoS One, 9(9), 2014, e107268.
40. Uhl, G.R., Walther, D., Musci, R., et al. Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. Mol. Psychiatry, 2012.
41. Wang, J., Spitz, M.R., Amos, C.I., Wilkinson, A.V., Wu, X., Shete, S., Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer 116:14 (2010), 3458–3462.
42. Wang, J., Spitz, M.R., Amos, C.I., et al. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One, 7(10), 2012, e47705.
43. Young, R.P., Hopkins, R.J., Hay, B.A., Epton, M.J., Black, P.N., Gamble, G.D., Lung cancer gene associated with COPD: triple whammy or possible confounding effect?. Eur. Respir. J. 32:5 (2008), 1158–1164.
44. Young, R.P., Hopkins, R.J., Whittington, C.F., Hay, B.A., Epton, M.J., Gamble, G.D., Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One, 6(2), 2011, e16476.